Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2021
Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunityEunsoo Kim, Zayed Attia, Rachel M Woodfint, et al.Proceedings of the National Academy of Sciences of the United States of America|August 22, 2022
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concernMijia Lu, Michelle Chamblee, Yuexiu Zhang, et al.Journal of Virology|August 11, 2021
A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in HamstersMijia Lu, Yuexiu Zhang, Piyush Dravid, et al.Proceedings of the National Academy of Sciences of the United States of America|August 6, 2025
Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmissionCheng Chih Hsu, Michelle Chamblee, Chengjin Ye, et al.Nature Communications|July 3, 2024
Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protectiveYuexiu Zhang, Michelle Chamblee, Jiayu Xu, et al.Proceedings of the National Academy of Sciences of the United States of America|March 10, 2021
A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spikeMijia Lu, Piyush Dravid, Yuexiu Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|July 27, 2022
A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spikeYuexiu Zhang, Mijia Lu, K C Mahesh, et al.Proceedings of the National Academy of Sciences of the United States of America|October 5, 2023
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concernJiayu Xu, Yuexiu Zhang, Panke Qu, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Caspase-11 Mediated Hyperinflammation Impairs CD8+ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 InfectionMostafa M Eltobgy, Mohamed M Shamseldin, Owen Whitham, et al.Proceedings of the National Academy of Sciences of the United States of America|May 19, 2022
Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosisMostafa M Eltobgy, Ashley Zani, Adam D Kenney, et al.Pageof 7